- Home
- THTX vs MNOV Comparison
THTX vs MNOV Comparison
Compare THTX & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- MNOV
- Stock Information
- Founded
- THTX 1993
- MNOV 2000
- Country
- THTX Canada
- MNOV United States
- Employees
- THTX N/A
- MNOV N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- MNOV Health Care
- Exchange
- THTX Nasdaq
- MNOV Nasdaq
- Market Cap
- THTX 93.3M
- MNOV 87.3M
- IPO Year
- THTX N/A
- MNOV 2005
- Fundamental
- Price
- THTX $1.72
- MNOV $1.83
- Analyst Decision
- THTX Hold
- MNOV Strong Buy
- Analyst Count
- THTX 1
- MNOV 1
- Target Price
- THTX N/A
- MNOV $9.00
- AVG Volume (30 Days)
- THTX 178.5K
- MNOV 37.0K
- Earning Date
- THTX 02-19-2025
- MNOV 02-13-2025
- Dividend Yield
- THTX N/A
- MNOV N/A
- EPS Growth
- THTX N/A
- MNOV N/A
- EPS
- THTX N/A
- MNOV N/A
- Revenue
- THTX $84,316,000.00
- MNOV N/A
- Revenue This Year
- THTX $5.78
- MNOV N/A
- Revenue Next Year
- THTX $2.47
- MNOV N/A
- P/E Ratio
- THTX N/A
- MNOV N/A
- Revenue Growth
- THTX 5.75
- MNOV N/A
- 52 Week Low
- THTX $1.08
- MNOV $1.12
- 52 Week High
- THTX $2.18
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- THTX 50.28
- MNOV 35.00
- Support Level
- THTX $1.69
- MNOV $1.90
- Resistance Level
- THTX $1.83
- MNOV $2.20
- Average True Range (ATR)
- THTX 0.13
- MNOV 0.08
- MACD
- THTX -0.04
- MNOV -0.03
- Stochastic Oscillator
- THTX 19.30
- MNOV 0.00
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.